SUMMARY The results of serological study of 40 cases of mumps virus infection are presented. Mumps virus was isolated from 20 of the patients studied and antibodies to the V antigen, the S antigen, and the haemagglutination antigen were performed in all cases. Analysis of these results shows that estimation of all three types of antibody is necessary to confirm the diagnosis in the maximum number of instances and that the long-accepted view that a characteristic pattern of antibody response is typical of the acute illness (namely, anti-S appearing earlier and in greater titre than anti-V) is questionable. 26 June 1979 mens were sent. Acute and convalescent serum samples were titrated in parallel from an initial dilution of 1 in 8 to a final dilution of 1 in 512 in microtitre plates. Detection of complement-fixing antibody to V and S antigens was by a standard technique,3 adapted for use in microtitre plates. Although sera showing fixation to levels beyond 1 in 512 were occasionally encountered, such results have been expressed as greater than or equal to 1 in 512 in order to allow the inclusion of several samples, insufficient of which remained to allow determination of the final end-point. All results were obtained on at least two separate testing occasions before being accepted as reproducible.
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It is recommended that serological tests for evidence of infection with mumps virus should include estimation of complement-fixing antibodies to both the virus particle (V) antigen and the soluble (S) antigen of the virus. ' This view has been held for some time and by other authors, for instance, Lennette and Schmidt.2 Furthermore, it is held by these authors that antibody to the S antigen appears early in the course of the disease (often within two to three days after the onset of clinical symptoms) whereas antibody to the V antigen appears much later. This disparity in the levels of the two antibodies in the early part of the illness, namely, S antibody being present earlier and in higher titre than V 26 June 1979 mens were sent. Acute and convalescent serum samples were titrated in parallel from an initial dilution of 1 in 8 to a final dilution of 1 in 512 in microtitre plates. Detection of complement-fixing antibody to V and S antigens was by a standard technique,3 adapted for use in microtitre plates. Although sera showing fixation to levels beyond 1 in 512 were occasionally encountered, such results have been expressed as greater than or equal to 1 in 512 in order to allow the inclusion of several samples, insufficient of which remained to allow determination of the final end-point. All results were obtained on at least two separate testing occasions before being accepted as reproducible.
Haemagglutination-inhibiting (HAI) antibody to mumps virus was measured by a microtitre method, using a virus dose of 4 haemagglutinating units (4HAU) of an antigen obtained by serial passage in fertile hens' eggs of the Enders strain of mumps virus. The passage was by the allantoic route. All sera were pretreated with receptor-destroying enzyme (RDE) and tested at dilutions from 1 in 10 to 1 in 640, acute and convalescent samples from the same patient being tested in parallel. Finally, a selection of the serum samples was re-tested for complement-fixing antibody to the V and S antigens using antigens prepared in the laboratory according to the methods of Lennette and Schmidt.2 In all instances, the results were not significantly different from those obtained with the standard antigens. These last results, therefore, are not presented below. Table 3 the serological findings in the remaining 20 patients in whom the evidence for infection with mumps virus is solely on serological grounds, the virus not having been recovered. Figure 1 shows the distribution of antibody levels to all three antigens in both acute and convalescent serum samples, and Fig. 2 relates the titre of antibody to the V antigen to that of the S antigen on the same serum sample, whether acute or convalescent.
Results

Discussion
The first and possibly the most important point to be made from the results of this study is that the recommendation that both V and S antigens should be routinely employed in testing for serological evidence- 5  64  32  80  26  64  32  40  8  2  <8  <8  20  21  256  128  20  9  4  8  8   <10   15  256  32  80  12  7  32  8  10  8  32  8  10  15  128  64  80  16  7  64  32  ins  19  >512  -512  80  17  2  <8  <8  10  30  64  16  20  18  4  32  8   <10   21  256  64  20  21  8  64  32  20  22  128  64  80  24  3  32  16  <10  30  128  64  40  26  2  64  64  <10  6  64  128  20  27  1  32  8  <10  23  :512  64  20  28  4  32  16  20  14  256  128  80  29  2  128  32  10  25  256  128  20  30  9  32  32  10  16  128  128  40  31  3  64  <8  <10  24  256  64  80  35  2  64  32  ins  30  >512  128  20  36  8  32  <8  10  21  128  32  40  37  4 Turning to the specific question posed in the introduction to this paper, it is clear that the results obtained in this study do not support the accepted view that antibody to the S antigen arises earlier and more rapidly in developing cases of mumps virus infection. Indeed, Fig. 1 shows that in the vast Freeman and Hamblintg majority of the cases considered here antibody to the V antigen appeared earlier than that to the S antigen. As is also shown in Fig. 1 , this is true even if consideration is restricted to those patients from whom the virus was isolated. Similarly, Fig. 2 demonstrates that production of antibody to the V antigen continues to be produced in excess of that to the S antigen, since when direct comparison of the two antibody levels on individual serum samples is made, the V antibody exceeds the S antibody in all but a few cases whether the sample is taken early in the illness or in convalescence. The statement that S antibody is more commonly present in acute serum than V antibody is attributed to Henle et al.4 It is not clear from this source what the total number of cases studied was, but it is certain that a substantial number of verified cases was investigated. Several explanations for the discrepancy can be put forward.
Firstly, there may be a difference in the antigens used. This seems unlikely since the standard antigens employed in the present study are prepared on very similar lines to those used by Henle et al. 4 In any case, a proportion of the sera in this study were retested with antigens prepared strictly by the protocol detailed by Henle in a standard text,2 and similar results were obtained. Secondly, Henle et al.4 make the point that, on several occasions, they encountered acute serum samples in which antibody to the S antigen showed marked pro zononing and partial fixation of complement over the low initial dilutions. Again, it is impossible for their report to determine the frequency of this phenomenon, but it has been observed by others, notably Enders et al.5 in studies using extracts of monkey parotid gland as a serological antigen (antigen thought to be predominantly of the S type). No such phenomenon was encountered in the present study, although had it occurred it is clear from the above reports that the procedures adopted of titrating the acute and convalescent sera in parallel at dilutions ranging from 1 in 8 to 1 in 512 would have revealed this. Thus, it seems that this explanation is unlikely.
A third possible explanation is that the epidemic strains of the mumps virus studied by Henle et al.4 and that responsible for the local outbreak from which these present cases are taken are antigenically different. This appears very unlikely, mumps virus being accepted as antigenically homogeneous and stable.' The possibility that the Enders strain used for the preparation of antigens has subtly altered through serial passage over the years could be excluded by direct comparisons on the materials and sera of the two eras. It is known that previous experience of infection with Thus, it appears that no obvious explanation for the differences exists. It is to be hoped that other laboratories involved in testing sera for evidence of mumps virus infection will provide confirmation of these findings, or refute them, and that by so doing some explanation will be found. Meanwhile, it is suggested that clinicians and laboratory workers involved in this field interpret the results of mumps virus serology with caution and that the previous practice of making a presumptive diagnosis based on the results of serological tests on the acute serum specimen be reviewed. On the results presented here such a diagnosis seems unwarranted. 
